Latest filing published 08 Sept 2022 for Eagle Pharmaceuticals, INC., €213k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Richard A. Edlin: trading record in brief
Richard A. Edlin appears in our data through filings on Eagle Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 22 March 2017 to 6 September 2022.
The open-market side counts 1 purchase for €441k alongside 1 sale for €213k. Purchases outweigh sales by €228k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2022 alone, the filings show no purchases and 1 sale.
The newest entry dates from 8 September 2022: an open-market sale of €213k, in Eagle Pharmaceuticals, Inc. The last purchase on record was published on 22 March 2017, which is 3,519 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Richard A. Edlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,800 shares@ US$30.99100.0% of flowCommon StockSEC:0001209191-22-049205:0
- 6,000 shares@ US$79.44Common StockSEC:0001209191-17-022324:0Canonical exit: 20 Jun 2017 (T+90)
2 of 2 declarations